No, no, no.<p>Why bother killing the tick after a tick bite has delivered Lyme's Borrelia burgdorferi spirochete? Even if it's effective at killing ticks, it won't stop Lyme transmission.<p>And for it to be effective at killing ticks, the human has to be completely steeped in this GABA channel blocker paralytic.<p>The eye drops offer no real safety guarantees because the dosages are no where near comparable. The human study of surface skin had no data on bites and a short observation period of 6 weeks (roughly the 11-day half-life x 5 half-lives to wash out the dose?).<p>----<p>The reported cost for ophthalmic 10ml solution of 0.25% lotilaner/Xdemvy for mites is ~$2k.<p>Reported adverse effects in dogs of lotilaner from 2013-2018 were only ~250, compared to 4k-18K for other drugs (no data on prevalence/usage).<p>It works as a GABA channel inhibitor (neurologic paralytic), specific to mites and perhaps ticks. No effect found in mammalian cells at ~11K/daily dosage for the ophthalmic drops.<p>Human blepharitis study had ~400 people in treatment arm over 6 weeks, ~50% effective.<p>Half-life of 11 days. No reported reversal agent. So if it is toxic, you're out of luck.<p>The optical solution is a tiny amount in the eyes, so little systemic exposure risk.<p>The tick pill involves much more systemic exposure via blood, so the eye drop experience says almost nothing about risk to humans.<p>I imagine the exposure to the tick from a blood bite is 10-1000x what it is from walking on the skin, so it's not clear to me this would stop lyme's Borrelia burgdorferi from being transmitted with the initial bite.<p>So: no.